Logistics of an advanced therapy medicinal product during COVID-19 pandemic in Italy: successful delivery of mesenchymal stromal cells in dry ice.

Giuseppe AstoriMartina BernardiAngela BozzaDaniela CatanzaroKatia ChieregatoAnna MerloMonica SantimariaRoberto BarbazzaGiuseppe AmodeoRachele CiccocioppoFrancesca EliceMarco Ruggeri

Published in: Journal of translational medicine (2020)

This experience underscores the flexibility of a public cell factory in its adaptation of the logistics of an advanced therapy medicinal product during a public health crisis. Alternative supply chains should be evaluated for other cell products to guarantee delivery during catastrophes.

Keyphrases

public health
cell therapy
single cell
healthcare
mental health
global health